Back to Journal

JSM Breast Cancer and Research

Nipple Adenoma of the Breast: Case Report of Uncommon Benign Tumor and Brief Review of the Literature

Abstract Citation Abbreviations Introduction Case Presntation Discussion Acknowledgment References
Details

Received: 08-Dec-2021

Accepted: 23-Dec-2021

Published: 27-Dec-2021

Madeleine Yeakle*, Kyle Coombes, Donya Ahmadian, Meha Munir, Christina Rolquin, Aly Bouquet, Victoria DeTrolio, and Mohamed Aziz 

Department of Pathology, American University of the Caribbean, USA

Corresponding Author:

Madeleine Yeakle, Department of Pathology. American University of the Caribbean, USA

Keywords

Adenoma; Breast; Benign; Epithelial; Myoepithelial

Abstract

Nipple adenoma is a very uncommon, benign proliferative process of lactiferous ducts of the nipple. It commonly presents unilaterally as a palpable nodule in the nipple or an erosive, scaly lesion of the nipple, with or without discharge. Resemblance to other conditions, such as Paget’s disease of the breast, psoriasis, eczema or tumors of the breast can delay diagnosis. The gold standard for treatment is surgical excision; however, newer modalities such as Mohs microsurgery and cryotherapy have been used in limited cases. In this report, we present a case of nipple adenoma and a review of the current literature.

Citation

Yeakle M, Coombes K, Ahmadian D, Munir M, Rolquin C, et al. (2021) Nipple Adenoma of the Breast: Case Report of Uncommon Benign Tumor and Brief Review of the Literature. JSM Breast Cancer Res 2: 3.

Abbreviations

NA: Nipple Adenoma; IHC: Immunohistochemistry

Introduction

Nipple adenoma (NA) is an uncommon, benign lesion defined as ‘a compact proliferation of small tubules lined by epithelial and myoepithelial cells, with or without proliferation of the epithelial component, around the collecting ducts of the nipple’[1].

NA presents most commonly in a middle-aged woman as a palpable nodule in the nipple with or without nipple skin erosion, crusting, inflammation, erythema, itching, and/or associated pain of the nipple region with or without discharge. The finding of serous and/or sanguineous discharge from the skin surface of the nipple profile is commonly reported as an initial presenting symptom and is generally secondary to the presence of a nipple skin erosive lesion [2]. Cases of nipple adenomas in men [3] and children [4-6] have been reported.

Resemblance to malignant conditions such as Paget’s disease or adenocarcinoma, as well as dermatologic conditions such as psoriasis, eczema, allergic contact dermatitis, molluscum contagiosum, hidradenoma papilliferum, and syringocystadenoma papilliferum [7] can delay diagnosis.

Treatment modalities include surgical excision, Mohs microsurgery, and cryotherapy [2]. Without treatment, nipple adenoma will continue to enlarge and cause local destruction of the nipple architecture [8]. Because this condition can be confused with malignancy, accurate diagnosis is important to prevent radical excision and unnecessary deformation of the breast [6].

Case Presntation

A 36-year-old woman presented with redness, and inflammation of the right nipple with itching and frequent non bloody discharge. The patient reported no significant medical history of family history. Physical examination revealed a small indurated right nipple nodule. Mammography and breast ultrasound did not provide adequate information. Contrast enhanced magnetic resonance imaging (MRI) suggested possible benign tumor with recommendation of tissue confirmation.

A multidisciplinary tumor board meeting recommended surgical excision of the nipple including the nodule with adequate safe surgical margins. The nipple was surgically removed followed by nipple reconstruction.

Microscopic examination of the excised nipple showed a dermal tumor infiltrating surrounding tissue measuring 0.8 cm (Figure 1A). The overlying skin showed hyperplasia with keratinization but no involvement by the adenoma. The proliferating tumor showed mixed pattern including papillomatosis and sclerosing papillomatosis giving pseudo infiltrating architecture. Branched tubular structures with micropapillary epithelial hyperplasia were noted (Figure 1B). Tubules were lined by two cell layers. The cell lining did not show any evidence of atypia or malignant features (Figure 1C). Immunohistochemistry studies were utilized to assist with definitive diagnosis. The myoepithelial cells stained positive with P63 (Figure 1D) and M-actin (Figure 1E). The epithelial cells stained positive with cytokeratin CK 5/6 (Figure 1F). In addition, cytokeratin CK7 was positive highlighting the ductal epithelium. The histomorphologic features together with the IHC profile were diagnostic of a mixed type benign nipple adenoma, completely excised.

The patient was followed for 22 months with no complications or recurrence after which she was lost to follow up.

Figure 1: Microscopic examination of the excised nipple adenoma
1A: Dermal tumor infiltrating surrounding tissue measuring 0.8 cm (H&E stain x10)
1B: Mixed pattern including papillomatosis and sclerosing papillomatosis giving pseudo-infiltrating architecture (H&E stain x20)
1C: Tubules lined by two cell layers. The cell lining show no evidence of atypia or malignant features (H&E stain x40)
1D: Tumor cells positive for P63 1E: Tumor cells positive for M-actin
1F: Tumor cells positive for CK 5/6

Discussion

Nipple adenoma (NA) is an uncommon, benign lesion defined as ‘a compact proliferation of small tubules lined by epithelial and myoepithelial cells, with or without proliferation of the epithelial component, around the collecting ducts of the nipple [1]. 2012 WHO guidelines designates this condition nipple adenoma, however, in past literature it has been referred to as florid papillomatosis of the nipple ducts, erosive adenomatosis, as well as subareolar papillomatosis, and papillary adenoma of the nipple [9].

Clinically, it often presents as an indurated nipple nodule, a visible nipple skin erosive lesion, with or without serous or bloody discharge from the surface of the nipple skin. Nipple adenoma may mimic benign conditions such as allergic contact dermatitis, psoriasis, seborrheic keratosis, and infection. Nipple adenomas also bear histologic resemblance to sweat gland tumors, especially hidradenoma papilliferum and syringadenoma papilliferum [7]. More importantly, it may be confused with Paget’s disease, keratoacanthoma, squamous cell carcinoma, or other unusual primary tumors of the nipple such as leiomyoma or mammary duct ectasia [5].

In the United States, breast cancer represents 29% of all new cancer diagnoses among women, second only to skin cancer [10]. Recognizing benign breast conditions, including those affecting the skin of the breast (like nipple adenoma), that can clinically and histologically mimic malignant conditions of the breast is therefore important to prevent radical excision and unnecessary deformation of the breast [6].

Due to the similarity in tissue density of the nipple to the surrounding skin and the underlying breast tissue, mammography and breast ultrasound cannot provide adequate information for confirming the presence of NA [2]. More advanced imaging modalities, such as breast magnetic resonance imaging (MRI), may be used to assess the extent of involvement of the tumor. The similarity in dynamic enhancement patterns between nipple adenoma and breast malignancy means the results of contrast enhanced MRI should be interpreted with caution [8]. A biopsy is the gold standard for diagnosing NA.

According to the WHO Classification of Tumors of the Breast [9], the 4 most common recognized histological subtypes of NA are: (1) adenosis type, (2) epithelial hyperplasia or papillomatosis type, (3) sclerosing papillomatosis or pseudo-infiltrating type, and (4) mixed type. The adenosis type is localized to the dermis and shows proliferating glands extending from collecting ducts. This type lacks hyperkeratosis, inflammation, erosion, and/ or ulceration. The papillomatosis type has hyperplasia of the collecting duct epithelia, forming solid tufts, and hyperplastic glandular ducts. The sclerosing papillomatosis type is characterized by a pseudo-infiltrating pattern with proliferating epithelium extending into the stroma. The papillomatosis type is most commonly misdiagnosed as Paget’s disease, but the presence of two prominent cell layers, the absence of cytologic atypia, and the presence of intraductal papillomatosis means that adenocarcinoma and therefore Paget’s disease can be excluded in most cases [7].

The presence of superficial keratocysts, intraluminal giant cells, intraductal papillomatosis, and the absence of true papillae support a diagnosis of NA over sweat gland tumors [7]. Immunohistochemistry (IHC) studies can be used to demonstrate the presence of two cell layers (i.e., epithelial and myoepithelial cells). p63, calponin 1, h-caldesmon, CK5/6, CD10, or alpha smooth muscle actin and smooth muscle myosin are specific for identifying myoepithelial cells. Cytokeratin CK7 highlights the ductal epithelium and further supports a diagnosis of nipple adenoma [11].

Nipple adenomas are biologically benign and complete surgical excision is standard therapy. Successful management with minimally invasive procedures, including Mohs micrographic surgery or cryosurgery, has also been reported but was restricted only to cases that were detected early on [8]. Without surgical excision, nipple adenoma will continue to enlarge and cause local destruction of the nipple architecture [8].

Although nipple adenomas are most commonly diagnosed in middle-aged women, cases of men and children have been reported. Albers et al reported a case of an 8 year old girl who presented with multiple white and flesh-colored lesions, measuring 1-2mm, scattered across her trunk and limbs. The child’s right nipple had a 4 mm, crusted, translucent papule. The initial diagnosis was molluscum contagiosum and the patient was treated with cantharidin. At follow-up, all lesions except the one on her nipple had resolved. A biopsy demonstrated that the remaining lesion was a nipple adenoma [5]. Clune et al reported the case of a 5-month old female infant presenting with a slowly enlarging nipple lesion. At the age of 23 months, a shave excision of the mass showed nipple adenoma [6]. Fujisawa et al reported a case of a 2 year old boy who presented with a firm, erythematous mass of the right nipple expressing serous discharge. Biopsy and subsequent excision confirmed a diagnosis of nipple adenoma [4]. Although almost all reported cases of nipple adenoma arose from central mammary tissue, Shioi et al described a case of nipple adenoma in axillary accessory breast tissue. In their case, an 82 year old woman presented with a well defined, painful, eczematous 8 mm mass in her right axilla. Upon excision, histological examination showed branched tubular structures with micropapillary epithelial hyperplasia, consistent with a “mixed type” nipple adenoma [12].

Occasional cases of malignancy co-occurring with nipple adenoma have been reported. Burdick et al described a case of a 53 year old man who presented with a bleeding left nipple. Over 8 years, the patient was followed and the mass continued to enlarge, with occasional bloody discharge. Biopsy of the mass demonstrated a nipple adenoma with an adjacent, well-defined area of Paget cells [3]. Sasi et al reported the case of a 63 year old woman presenting to the clinic with an eczematous, crusted right nipple that was inverted and expressing yellow discharge. The patient had a history of left-sided ductal carcinoma in situ and nipple adenoma. Upon surgical excision, histopathological examination showed that the right breast had evidence of nipple adenoma making this a case of bilateral nipple adenoma with metachronous breast cancer in the left breast [13]. Although cases of nipple adenoma co-occurring with malignancy have been reported, the association between the two entities remains unclear. Regular follow-up with patients with a history of nipple adenoma is recommended to exclude breast cancer [8].

We hope that reporting this case will raise the awareness of pathologists and clinicians to include the nipple adenoma in the differential diagnosis of nipple lesions. Early proper diagnosis of this benign tumor is essential to prevent radical excision and unnecessary deformation of the breast.

Acknowledgment

Special thanks to Marissa Conde, Victoria Echevarria, and Daniel Hildebrandt, MD candidates, American University of the Caribbean for their assistance in reviewing the final manuscript.

References

1. Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press; Lyon: 2003. World Health Organization Classification of Tumors.

2. Spohn GP, Trotter SC, Tozbikian G, Povoski SP. Nipple adenoma in a female patient presenting with persistent erythema of the right nipple skin: case report, review of the literature, clinical implications, and relevancy to health care providers who evaluate and treat patients with dermatologic conditions of the breast skin. BMC Dermatol. 2016 May 20;16(1):4. doi: 10.1186/s12895-016-0041-6. PMID: 27206635; PMCID: PMC4873987.

3. Burdick C, Rinehart RM, Matsumoto T, O’Connell TJ, Heisterkamp CW. Nipple adenoma and Paget’s disease in a man. Arch Surg 1965;91:835-9

4. Fujisawa K, Kato M, Kono T, Utsunomiya H, Watanabe A, Watanabe S. Nipple adenoma in a 2-year-old boy. Pediatr Dermatol 2018;35:e184-5

5. Albers SE, Barnard M, Thorner P, Krafchik BR. Erosive adenomatosis of the nipple in an eight-year-old girl. J Am Acad Dermatol 1999;40:834-7.

6. Clune, J. E., Kozakewich, H. P., VanBeek, C. A., Labow, B. I., & Greene,A. K. (2009). Nipple adenoma in infancy. Journal of Pediatric Surgery, 44(11), 2219–2222.doi:10.1016/j.jpedsurg.2009.08

7. Brownstein MH, Phelps RG, Magnin PH. Papillary ade- noma of the nipple: analysis of fifteen new cases. J Am Acad Dermatol 1985;12:707-15.

8. Yang TT, Su YC, Lan CCE. Nipple adenoma: A report of two cases. Dermatol Sin 2020;38:102-4

9. Breast Tumors: WHO Classification of Tumors (Medicine) 5th Edition. World Health Organization; 5th edition (December 3, 2019)

10. American Cancer Society . Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society, Inc; 2015.

11. DI Bonito M, Cantile M, Collina F, D’Aiuto M, Liguori G, DE Cecio R, Botti G. Adenoma of the nipple: A clinicopathological report of 13 cases. Oncol Lett. 2014 Jun;7(6):1839-1842. doi: 10.3892/ol.2014.2000. Epub 2014 Mar 28. PMID: 24932244; PMCID: PMC4049716.

13. Shioi Y, Nakamura S, Kawamura S, Kasami M. Nipple adenoma arising from axillary accessory breast: a case report. Diagn Pathol. 2012 Nov 27;7:162. doi: 10.1186/1746-1596-7-162. PMID: 23186145; PMCID: PMC3527299.

13. Sasi W, Banerjee D, Mokbel K, Sharma AK. Bilateral Florid Papillomatosis of the Nipple: An Unusual Indicator for Metachronous Breast Cancer Development—A Case Report. Case Reports in Oncological Medicine. 2014,Article ID 432609, 3 pages, 2014. https:// doi.org/10.1155/2014/432609

Other Articles

Article Image 1

Neoadjuvant Chemotherapy for Breast Cancer and the Impact of Pathologic Complete Response

Introduction: Neoadjuvant chemotherapy for breast cancer over the last several years is being utilized with increasing frequency. Neoadjuvant therapy can potentially downstage advanced regional disease, increasing the likelihood of negative surgical margins. This study analyzes the utilization and outcomes of neoadjuvant chemotherapy for breast cancer at a single institution.

Methods: A retrospective chart review was performed at the Jacqueline M Wilentz Breast Center in Long Branch, New Jersey. All patients from 2010 to present that underwent neoadjuvant chemotherapy for breast cancer were analyzed. The initial biopsy pathology, initial staging workup, response to therapy, operation, surgical pathology reports were studied. Chi square analysis was then used to identify factors more likely to yield a pathologic complete response. Finally, outcomes in patients that did and did not have a pathologic complete response were examined.

Results: The most common indications for neoadjuvant therapy for advanced regional disease and Her2 positive status. The tumor was successfully downstaged in 29 of 46 patients (63.0%), with 13 (28.3%) achieving pathologic complete response. The major predictors of pathologic complete response were chemotherapy regimen and Her2 status, as 12 of 21 patients (57.1%) patients with amplified Her2 and 8 of 12 (66.7%) patients receiving TCHP therapy achieving pCR. Predictive factors of residual disease included triple negative status and treatment with ACT chemotherapy. Pathologic complete response was predictive of favorable prognosis, as no patient that achieved a pCR had recurrence, local or distant, within the time frame of this study. Factors predictive of recurrence included residual nodal disease or residual tumor T3 or greater.

Conclusion: In our retrospective study, neoadjuvant chemotherapy successfully downstages patients in the majority of patients. The patients that were able to derive the most benefit from neoadjuvant therapy were those with Her2 amplified tumors, and those that underwent therapy with TCHP. Achievement of pCR incurred a favorable prognosis.

Brian Shea¹, Genevieve Fasano¹, William P. Boyan¹, Natalie Lopyan¹, Manpreet Kohli¹ and Seth Cohen²*


Article Image 1

Bilateral Invasive Histiocytoid Lobular Breast Carcinoma with Massive Paget’s Disease. Case Report of Rare Tumor with a Controversial Histogenesis and Review of the Literature

Histiocytoid breast carcinoma (HBC) is a rare type of breast cancer with a controversial histogenesis, generally considered to be a variant of invasive lobular carcinoma. It comprises fewer than 0.3% of breast cancer cases. Published reports on this neoplasm are sparse and there exists a significant diagnostic challenge when differentiating these tumors from other tumors with similar presentations. Paget’s disease of the breast comprises up to 3% of all breast malignancies. The majority of Paget’s disease cases are associated with ductal carcinoma in situ, with bilateral, multifocal, and synchronous pathology rarely reported. While bilateral presentation of invasive lobular carcinoma is well documented, synchronous and metachronous forms are rare. We present a case of a 20-year-old female with bilateral invasive histiocytoid lobular breast carcinoma and concurrent massive bilateral Paget’s disease of the breast. The goal of this manuscript is to explore possible pathologic associations and to clarify diagnostic parameters based on current literature.

Amber Latif¹, Deogratias Ruhangaza², Petr Stastka¹, Timidayo Fadelu³, Nicaise Nsabimana², Callie Weber⁴, Breanna Barnard¹, Stephanie Bernik⁵, and Mohamed Aziz¹*


Article Image 1

Primary Angiosarcoma of the Breast: Case Report of Uncommon Tumor and Brief Review of the Literature

Primary angiosarcoma of the breast is uncommon and only diagnosed in roughly 0.04% of all malignant breast tumors. Only 20% of these cases are primary malignancies while the remaining are complications of radiation therapy. Diagnosis is difficult because it tends to mimic benign characteristics on mammogram and histology. Although it can appear benign, breast angiosarcoma is an aggressive, malignant tumor with a poor prognosis. Radiologic imaging along with immunostaining with Factor VIII and CD31 can confirm the presence of angiosarcoma. Currently, surgery is the only treatment option that improves the clinical outcome of the disease, with little help from chemotherapy.

Olivia Weller*, Jocelyn Lubert, Justin Shirah, Kailee Fernandes, Todd Furr, Joseph Rogers, Graeme Benzie, Mohamed Aziz 


Article Image 1

Diagnosis of Mammary Paget’s Disease by Cytology Sampling. Case Report and Brief Review of the Literature

Mammary Paget’s disease (MPD) of the breast is a rare form of breast cancer. It accounts for a very small percentage of breast cancers in women, and much less in men It rarely occurs as an isolated entity and is usually associated with carcinoma in situ or invasive adenocarcinoma in most cases. In situ histology is seen in one third of the cases. Paget’s disease is rarely diagnosed in people under the age of 45. Paget’s disease affects people of all ethnic and racial groups. However, people of Asian descent are less likely to be affected. Surgical treatment of Paget’s disease (radical or conservative) is controversial. There is no established standardized treatment, and treatment decisions are based on other associated conditions. There is currently no evidence that either surgical approach (conservative surgery or mastectomy) improves survival. Prognosis depends on the presence of a palpable mass and the invasiveness of the cancer. We present a case of a 37-year-old woman who presented with recurrent mixed ductal lobular carcinoma associated with Paget’s disease. Paget’s disease diagnosis was completely established based on cytology material sampling only. The patient was treated with bilateral mastectomy with no nipple sparing. The patient was followed for four years with no evidence of metastasis or recurrence.

Christina Rolquin¹, Madilyn Thomas¹, Meha Munir¹, Victoria DeTrolio¹, Jonathan Nguyen¹, Viviana Crespo¹, Hadel Go², Alan Bencosme³, Jessica Jahoda¹,⁴, and Mohamed Aziz MD⁴*


Article Image 1

High-Resolution-MRI of the Breast Including All Locoregional Lymph Nodes: All-In-One with Additional Use of a Body Coil on the Back (Sandwich Concept)

  • Background: Breast MRI is a valuable tool, especially for women with dense breasts, but its visualization of all local lymph nodes is limited.

  • Purpose: To demonstrate a breast MRI technique using a body coil on the back in addition to a breast surface coil to improve imaging of the breast and locoregional lymph nodes.

  • Materials and Methods:

    • Breast MRI performed with a dedicated surface coil AND a second coil on the back.

    • Prone position.

    • High spatial resolution ("MIO Breast MRI").

    • Total examination time: 8:32 minutes for the breast MRI portion.

    • Included T2 measurement and dynamic T1 sequences (before and twice after 5 ml gadobutrol – a first-pass technique).

    • Additional coronal fat-suppressed T1 VIBE DIXON sequence:

      • 52 slices, 3mm thickness

      • Matrix 320 x 240

      • TR 4.2ms, TE 1.34/2.57ms

      • FOV 420mm

      • Measurement time: 16 seconds

  • Results: The "sandwich technique" (breast coil + body coil) enabled detection of breast carcinomas AND imaging of axillary, infra-, supraclavicular, and parasternal lymph nodes. Total measurement time was 8:48 minutes (8:32 breast MRI + 16 seconds for lymph nodes). Optional lymph node imaging before contrast agent administration could be done in an additional 16 seconds.

  • Conclusion: Combining breast and body surface coils provides high-quality breast MRI and sufficient imaging of all locoregional lymph nodes in under 10 minutes. This is particularly useful for preoperative local MR staging.

Fischer Uwe*, El Hajab Anja, Meiser Nadia, Baum Friedemann, and Rüschoff Jutta